Globus Medical Inc (GMED) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Globus Medical reported revenue of $2.94B, up 16.7% from $2.52B the year before. Net income was $537.9M (a 18.3% net margin), or $3.92 per diluted share. Gross margin was 67.4% and operating margin was 16.3%. Operating activities generated $753.4M of cash, leaving $588.8M of free cash flow. At fiscal year end, Globus Medical held $5.30B in total assets against $729.5M in total liabilities, including $526.2M of cash and equivalents.
Open the full interactive Globus Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Globus Medical Key Stats
| Share Price | $76.32 |
|---|---|
| Market Cap | $10.49B |
| P/E Ratio | 19.5 |
| Revenue YoY Growth | +16.7% |
| 52-Week Range | $57.49 – $96.82 |
| Shares Outstanding | 135.1 million (basic, 2026 Q2) |
Globus Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $789.0M | $958.1M | $1.02B | $1.57B | $2.52B | $2.94B |
| Cost of Goods Sold | $217.5M | $239.2M | $263.7M | $548.2M | $1.04B | $957.8M |
| Gross Profit | $571.6M | $718.9M | $759.1M | $1.02B | $1.48B | $1.98B |
| Operating Income | $111.4M | $172.0M | $228.0M | $133.1M | $166.0M | $479.8M |
| Pre-Tax Income | $125.9M | $180.4M | $243.0M | $165.4M | $120.7M | $605.1M |
| Income Tax | $23.6M | $31.2M | $52.9M | $42.5M | $17.7M | $67.2M |
| Net Income | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M |
| Diluted EPS | $1.01 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 |
Globus Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $769.0M | $826.4M | $759.9M | $789.6M |
| Net Income | $119.0M | $140.6M | $124.3M | $151.6M |
| Diluted EPS | $0.88 | $1.03 | $0.90 | $1.10 |
Globus Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | — | — | — | — | — | $526.2M |
| Current Assets | $821.8M | $864.5M | $983.3M | $1.92B | $2.18B | $2.13B |
| Total Assets | $1.68B | $1.96B | $2.08B | $5.09B | $5.25B | $5.30B |
| Current Liabilities | $120.8M | $140.2M | $159.2M | $392.3M | $855.9M | $498.5M |
| Total Long-Term Debt | — | — | — | $417.4M | — | — |
| Total Liabilities | $173.2M | $215.9M | $229.8M | $1.09B | $1.07B | $729.5M |
| Shareholders' Equity | $1.51B | $1.74B | $1.85B | $4.00B | $4.18B | $4.57B |
Globus Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $198.8M | $276.3M | $178.5M | $243.5M | $520.6M | $753.4M |
| Cash From Investing | -$117.3M | -$375.9M | -$110.4M | $303.0M | -$176.1M | -$355.0M |
| Cash From Financing | -$38.7M | $54.1M | -$110.0M | -$231.8M | -$27.7M | -$679.2M |
| Free Cash Flow | $135.1M | $219.4M | $104.4M | $165.2M | $405.2M | $588.8M |
Figures from Globus Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Globus Medical financials page for every line item.
Globus Medical Company Profile
| Ticker | GMED |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Audubon, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001237831 |
Frequently Asked Questions
What was Globus Medical's revenue in fiscal 2025?
Globus Medical (GMED) reported revenue of $2.94B for fiscal 2025.
What is Globus Medical's annual revenue history?
Globus Medical's annual revenue by fiscal year: 2020: $789.0M; 2021: $958.1M; 2022: $1.02B; 2023: $1.57B; 2024: $2.52B; 2025: $2.94B.
What was Globus Medical's net income in fiscal 2025?
Globus Medical reported net income of $537.9M for fiscal 2025.
What was Globus Medical's earnings per share (EPS) in fiscal 2025?
Globus Medical's diluted EPS was $3.92 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Globus Medical generate in fiscal 2025?
Globus Medical generated $588.8M of free cash flow in fiscal 2025.
What was Globus Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Globus Medical reported revenue of $789.6M.
How many shares of Globus Medical are outstanding?
Globus Medical reported a weighted average of 135.1 million basic shares outstanding in 2026 Q2.
What is Globus Medical's market cap?
Based on its latest closing price, Globus Medical (GMED) has a market capitalization of about $10.49B.
When does Globus Medical's fiscal year end?
Globus Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Globus Medical headquartered?
Globus Medical lists its business address in Audubon, Pennsylvania in its SEC filings.